The MPN Panel 3 is a genetic test that detects vital mutations associated with myeloproliferative neoplasms (MPNs), a type of blood cancer. It helps doctors diagnose and classify MPNs, plan treatment, and monitor disease progression.
DiagnosticsHealth package
For men & women336 hours4 testsHome collection
Know more about this package
The MPN Panel 3 is a genetic test that detects vital mutations associated with myeloproliferative neoplasms (MPNs), a type of blood cancer. It helps doctors diagnose and classify MPNs, plan treatment, and monitor disease progression.
Understanding MPN Panel 3
Chronic myeloproliferative neoplasms (MPNs) are blood disorders in which the bone marrow produces too many red blood cells, white blood cells, or platelets. The {tet_name} is a comprehensive blood test used to evaluate genetic changes in blood cells that are characteristic of MPNs.
The MPN Panel Advanced detects key genetic mutations and fusions, including CALR, JAK2 (exons 12–15), MPL, and the BCR-ABL fusion. This helps doctors identify and classify different types of myeloproliferative neoplasms (MPNs), in...
CALR is a genetic test that helps identify abnormalities in a gene called calreticulin (CALR) which is an important indicator of the development of conditions such as essential thrombocythemia (ET), a rare blood disorder and primary myelofibrosis (PMF). Abnormalities (mutations) in the CALR gene cause signs and symptoms of myeloproliferative neoplasms (MPN). This test is mostly used to analyze diagnostic and prognostic information in patients with myeloproliferative neoplasms (MPNs) when JAK2 testing is negative.
